Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized double-blind trial of Irsogladine maleate for NSAID or aspirin-induced peptic ulcer and gastritis
KCT0002319Phase 3Completed
- Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of irsogladine in Peptic ulcer disease (PUD) and gastritis (2 arms), sponsored by Taejoon Pharmaceutical Co., Ltd. Started Jan 2015; status: completed.
02
Drugs
irsogladine
03
Conditions
Peptic ulcer disease (PUD)gastritis
Beyond the preview
Go deeper on KCT0002319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002319.